SG Americas Securities, LLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 120 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$57
-43.6%
38,743
+11.6%
0.00%0.0%
Q1 2023$101
+14.8%
34,707
+29.0%
0.00%0.0%
Q4 2022$88
-99.9%
26,915
-15.3%
0.00%0.0%
Q3 2022$120,000
-77.1%
31,793
-52.7%
0.00%
-83.3%
Q2 2022$524,000
-72.7%
67,211
-67.4%
0.01%
-57.1%
Q1 2022$1,917,000
-44.3%
206,374
-5.5%
0.01%
-26.3%
Q4 2021$3,441,000
-23.2%
218,354
-12.7%
0.02%
-9.5%
Q3 2021$4,480,000
+45.0%
250,253
+25.9%
0.02%
+50.0%
Q2 2021$3,090,000
+175.4%
198,726
+154.3%
0.01%
+133.3%
Q1 2021$1,122,000
+303.6%
78,160
+451.5%
0.01%
+500.0%
Q4 2020$278,000
-23.2%
14,173
-49.3%
0.00%
-50.0%
Q3 2020$362,000
+293.5%
27,953
+158.2%
0.00%
+100.0%
Q1 2020$92,000
-29.8%
10,828
+35.8%
0.00%0.0%
Q4 2019$131,000
-68.4%
7,973
-23.6%
0.00%
-75.0%
Q1 2019$415,000
+20.3%
10,432
+5.1%
0.00%
+33.3%
Q4 2018$345,000
+219.4%
9,929
+278.5%
0.00%
+200.0%
Q3 2018$108,000
+0.9%
2,623
-4.6%
0.00%0.0%
Q1 2018$107,000
-24.6%
2,749
-67.9%
0.00%0.0%
Q3 2017$142,000
+35.2%
8,553
+67.1%
0.00%0.0%
Q1 2017$105,000
-32.3%
5,120
-53.1%
0.00%0.0%
Q4 2016$155,000
+3.3%
10,926
+129.7%
0.00%0.0%
Q3 2015$150,0004,7570.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 2,932,865$48,304,0003.48%
Camber Capital Management LP 2,950,000$48,587,0002.47%
Trellus Management Company, LLC 87,873$1,447,0002.42%
Redmile Group, LLC 4,648,570$76,562,0001.83%
Baupost Group 8,308,900$136,848,0001.51%
MAVERICK CAPITAL LTD 4,958,431$81,665,0001.19%
Artal Group S.A. 1,750,000$28,823,0001.11%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 175,000$2,882,0000.36%
12 West Capital Management LP 158,700$2,614,0000.16%
WASATCH ADVISORS LP 1,101,103$18,135,0000.15%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders